Asset Manager

Updated:

Bayer Environmental Science Professional

Envu, the former Bayer Environmental Science Professional unit, operates post-Cinven carve-out focused on professional pest management solutions.

Bayer Environmental Science Professional

Bayer AG formally sold its Environmental Science Professional business to international private equity firm Cinven in October 2022, following a strategic review that identified the unit as non-core to Bayer’s crop-science and pharmaceutical divisions. The $2.6 billion all-cash deal (per Bloomberg, 2022) transferred ownership of a portfolio comprising pest-control hardware, professional turf management solutions, and public-health vector-control products historically distributed under brands like Maxforce, Temprid, and DeltaGard. While Bayer retains no equity stake, Cinven established a new corporate identity — later branded as Envu following regulatory approvals — headquartered in Cary, North Carolina, with the explicit mandate to invest in product innovation without the legacy conglomerate’s overhead. The portfolio covers three primary professional-use verticals: structural pest-control products for commercial and residential service providers, turf and ornamental solutions for golf courses and landscape professionals, and insecticide-based vector control for municipal and public-health agencies. Cinven’s holding structure allows the former Bayer unit to pursue bolt-on acquisitions and partnerships directly, rather than compete for capital allocation inside a publicly traded life-sciences giant. The firm’s geographic footprint extends across North America, Europe, and Asia-Pacific — markets where the Bayer legacy distribution relationships provide immediate commercial access. As of late 2024, Envu operates as a standalone platform within Cinven’s portfolio, with no disclosure of fund-level deployment benchmarks or carry structures. Cinven appointed Gilles Galliou — a former Bayer environmental-science executive who had led the business since 2019 — as CEO of the carved-out entity, ensuring operational continuity during the ownership transition. In January 2024, Envu announced its first post-Carve acquisition of AgBiome’s fungicide assets (per Envu press release, 2024), signaling an inorganic growth strategy under Cinven’s ownership. The platform’s total addressable market remains anchored to professional pest management, an industry projected to exceed $30 billion globally, though Cinven’s specific investment theses for value creation remain private. Envu’s structural differentiator is its position as a carve-out from a global conglomerate, now operating as a pure-play environmental-science platform inside a financial sponsor’s portfolio. Unlike competitors still embedded within diversified public companies, Envu can allocate capital exclusively to professional product development, pursue add-on acquisitions without quarterly earnings pressure, and structure management incentives tied directly to the fund’s exit horizon rather than parent-company stock performance.

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Cary

Corporate office

Cary, NC, United States

Sector focus

AgriTech & FoodTechReal Estate

Frequently asked questions

Who owns the Bayer Environmental Science Professional business now?

The unit was sold by Bayer AG to private equity firm Cinven in a $2.6 billion transaction that closed in October 2022 (per Bloomberg, 2022). The business was subsequently rebranded as Envu and operates as a standalone portfolio company within Cinven’s fund structure. Bayer retains no equity interest or operational control.

What does Envu actually sell?

Envu sells professional-grade pest-control products, turf and ornamental management solutions, and vector-control insecticides. Its customer base includes commercial exterminators, golf course superintendents, landscaping firms, and municipal health agencies. The product portfolio was historically marketed under Bayer brands including Maxforce, Temprid, and DeltaGard.

Is Envu still connected to Bayer’s pharmaceutical or crop-science divisions?

No. The 2022 transaction fully separated the Environmental Science Professional unit from Bayer AG. Cinven now owns the business outright, and Envu operates with its own management team, supply chain, and R&D budget independent of Bayer. There is no shared governance, cross-ownership, or licensing dependency.

Who runs investment decisions at Envu?

Strategic and capital-allocation decisions are made by Envu’s management team under CEO Gilles Galliou, subject to Cinven’s oversight as the controlling shareholder. Cinven typically governs via a portfolio board, and any material acquisitions or divestitures require sponsor approval. Executive compensation is structured around Cinven’s eventual exit.

Does Envu operate as an investment manager, or is it an operating company?

Envu is an operating company — not an investment manager. It manufactures and distributes professional pest-management and vegetation-control products. Cinven’s fund holds the investment on behalf of its limited partners, but Envu itself does not manage third-party capital or run an investment program.

What was Envu’s first acquisition after the carve-out?

Envu acquired certain fungicide assets from agricultural biotechnology company AgBiome in January 2024 (per Envu press release, 2024). The transaction added biological and conventional fungicide products to Envu’s turf and ornamental portfolio, representing the platform’s first inorganic growth move under Cinven ownership.

Is Envu’s financial performance publicly available?

No. As a Cinven portfolio company, Envu does not file public financial statements. Revenue, EBITDA, and deployment metrics are reported to Cinven’s limited partners on a confidential basis. Prior to the carve-out, the unit generated approximately €600 million in annual sales within Bayer’s crop-science segment (per Bayer annual report, 2021).

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Cary Asset Manager profiles